Healthcare Costs Prevented Nearly 40 Million Americans From Filling Their Prescriptions in 2008

December 17, 2008
Nearly 40 million U.S. adults decided not to fill a prescription medication from a doctor in the past year because of the cost, according to pharmaceutical and healthcare market research company Manhattan Research's Cybercitizen Health v8.0 consumer study and strategic advisory service. The study found that women and patients with neurological and mental health conditions were the most likely to give up their medication due to cost. Read more...

Other Drug News

The latest Pharmaceutical News & Articles brought to you by Drugs.com

NovaDel Pharma Receives FDA Approval of ZolpimistDecember 22, 2008
NovaDel Pharma Inc. has announced that Zolpimist (zolpidem tartrate) 5 mg and 10 mg Oral Spray has been approved by the U.S. Food and Drug Administration (FDA) for the short-term treatment of insomnia characterized by difficulties with sleep initiation.

Antisoma Receives FDA Approval for Oral Fludarabine19 December 2008
Antisoma plc has announced that the United States Food and Drug Administration (FDA) has approved its tablet formulation of fludarabine phosphate ('oral fludarabine') as a second-line treatment for chronic lymphocytic leukemia (CLL).

FDA Wants New Diabetes Drugs Tested for Heart RisksDecember 17, 2008
The U.S. Food and Drug Administration is now asking all companies looking for approval of new type 2 diabetes medications to undertake studies that determine whether they cause cardiovascular problems.

FDA Requires Warnings about Risk of Suicidal Thoughts and Behavior for Antiepileptic MedicationsDecember 16, 2008
The U.S. Food and Drug Administration today announced it will require the manufacturers of antiepileptic drugs to add to these products' prescribing information, or labeling, a warning that their use increases risk of suicidal thoughts and behaviors (suicidality). The action includes all antiepileptic drugs including those used to treat psychiatric disorders, migraine headaches and other conditions, as well as epilepsy.

FDA Faults Drug Information for ConsumersDecember 16, 2008
The printed consumer information that accompanies new prescription drugs is often difficult to read or understand, the U.S. Food and Drug Administration has said.

Experimental Weight-Loss Pill Passes Early TestDecember 12, 2008
Researchers are hoping that an experimental new weight-loss drug will prove to be a valuable new weapon in the crusade against obesity. In recently released phase 2 trials, the drug, known as lorcaserin, resulted in substantial weight loss in obese men and women.

HRT Users Who Get Breast Cancer Less Likely to DieDecember 12, 2008
Taking hormone therapy after menopause is known to increase the risk of getting breast cancer, but women who take hormone therapy and then develop breast cancer have a lower risk of dying from the disease, a new study suggests.

About This Newsletter

Drugs.com is not affiliated with any pharmaceutical company. We are dedicated to providing consumers and health professionals with objective information about prescription-medication discoveries and side effects.

This information is not intended to be medical advice. You should contact your physician before making any changes to your health care. Drugs.com is not responsible for content provided by third-party web sites.

Your Feedback

We always appreciate feedback so if you wish to give us your comments/ praise/ rebuke please Contact Us.

Thanks so much for your continued support!
The Editorial TeamDrugs.com